|
Q4 FY2025
As of Dec 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
Q2 FY2020
As of Jun 30, 2020
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS: | ||||||||||||||||||||
| Leasing equipment, net of accumulated depreciation of $3,595,069 and $4,776,458 | ||||||||||||||||||||
| Net investment in finance leases | ||||||||||||||||||||
| Equipment held for sale | ||||||||||||||||||||
| Revenue earning assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Total cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Accounts receivable, net of allowances of $2,504 and $1,317 | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Lease intangibles, net of accumulated amortization of $297,803 and $296,494 | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total other assets | ||||||||||||||||||||
| Fair value of derivative instruments | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND SHAREHOLDERS' EQUITY: | ||||||||||||||||||||
| Equipment purchases payable | ||||||||||||||||||||
| Fair value of derivative instruments | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Accounts payable and other accrued expenses | ||||||||||||||||||||
| Total accounts payable and other accrued expenses | ||||||||||||||||||||
| Net deferred income tax liability | ||||||||||||||||||||
| Debt, net of unamortized costs of $39,373 and $48,743 | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Shareholders' equity: | ||||||||||||||||||||
| Preferred shares, $0.01 par value, at liquidation preference | ||||||||||||||||||||
| Common shares, $0.01 par value, 210,000,000 and 250,000,000 shares authorized, 101,158,891 shares issued and outstanding | ||||||||||||||||||||
| Undesignated shares, $0.01 par value, 54,800,000 and 20,800,000 shares authorized, no shares issued and outstanding | ||||||||||||||||||||
| Treasury Stock, Shares (in shares) | ||||||||||||||||||||
| Total treasury Stock, Shares (in shares) | ||||||||||||||||||||
| Treasury shares, at cost, 0 and 24,494,785 shares, respectively | ||||||||||||||||||||
| Total treasury shares, at cost, 0 and 24,494,785 shares, respectively | ||||||||||||||||||||
| Additional paid-in capital (deficit) | ||||||||||||||||||||
| Total additional paid-in capital (deficit) | ||||||||||||||||||||
| Accumulated earnings | ||||||||||||||||||||
| Total accumulated earnings | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||||
| Total accumulated other comprehensive income (loss) | ||||||||||||||||||||
| Total shareholders' equity | ||||||||||||||||||||
| Liabilities and shareholders' equity | ||||||||||||||||||||
| Total liabilities and shareholders' equity | ||||||||||||||||||||
Loading...
